Walleye Capital
CLOV icon

Walleye Capital’s Clover Health Investments CLOV Stock Holding History

Walleye Capital’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.9K Sell
10,289
-14,223
-58% -$48.3K ﹤0.01% 4159
2026
Q1 		$43.1K Sell
24,512
-82,689
-77% -$179K ﹤0.01% 3937
2025
Q4 		$252K Buy
107,201
+28,409
+36% +$77.7K ﹤0.01% 3419
2025
Q3 		$241K Sell
78,792
-210,404
-73% -$601K ﹤0.01% 3187
2025
Q2 		$807K Buy
289,196
+286,280
+9,818% +$941K ﹤0.01% 2224
2025
Q1 		$10.5K Sell
2,916
-38,014
-93% -$153K ﹤0.01% 4060
2024
Q4 		$129K Buy
+40,930
New +$146K ﹤0.01% 4009
2022
Q2 		– Sell
-59,002
Closed -$209K – 2404
2022
Q1 		$209K Buy
59,002
+2,602
+5% +$7.54K 0.01% 1500
2021
Q4 		$210K Buy
+56,400
New +$346K 0.01% 1444
2020
Q4 		– Sell
-101,030
Closed -$1.26M – 958
2020
Q3 		$1.26M Sell
101,030
-100,809
-50% -$1.12M 0.14% 200
2020
Q2 		$2.26M Buy
+201,839
New +$2.17M 0.5% 48

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Capital's CLOV Position: Q2 2026 in Review

Walleye Capital reduced its Clover Health Investments (CLOV) stake by 58% in Q2 2026, selling an estimated $48.3K and leaving 10,289 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

Walleye Capital first reported a position in CLOV in Q2 2020 and has held it in 11 quarters since. The position peaked at $2.26M in Q2 2020. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Walleye Capital held 10,289 shares of Clover Health Investments worth $53.9K as of Q2 2026.
  • Walleye Capital sold 14,223 Clover Health Investments shares in Q2 2026, an estimated $48.3K.
  • Clover Health Investments made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4159 holding.
  • Walleye Capital first reported a position in Clover Health Investments in Q2 2020 and has held it in 11 quarters since.
  • Walleye Capital's Clover Health Investments position peaked at $2.26M in Q2 2020.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.